The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Compass Pathways Plc ADR shares valued at $16,093,000 were sold by ATAI Life Sciences N.V. on Sep 26 ’24. At $6.05 per share, ATAI Life Sciences N.V. sold 2,660,000 shares. The insider’s holdings dropped to 6,905,774 shares worth approximately $28.59 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Malievskaia Ekaterina sold 8,900 shares, netting a total of over 70,379 in proceeds. Following the sale of shares at $7.91 each, the insider now holds 3,931,687 shares.
Before that, Malievskaia Ekaterina had sold 8,900 shares from its account. In a trade valued at $70,379, the 10% Owner traded Compass Pathways Plc ADR shares for $7.91 each. Upon closing the transaction, the insider’s holdings decreased to 8,900 shares, worth approximately $16.27 million.
As published in their initiating research note from RBC Capital Mkts on July 23, 2024, Compass Pathways Plc ADR [CMPS] has been an Outperform and the price target has been revised to $23. Analysts at Morgan Stanley started covering the stock with ‘”an Overweight”‘ outlook in a report released in early April. As of December 12, 2023, Deutsche Bank has initiated its “Buy” rating for CMPS.
Analyzing CMPS Stock Performance
During the last five days, there has been a surge of approximately 5.34%. Over the course of the year, Compass Pathways Plc ADR shares have dropped approximately -52.69%. Shares of the company reached a 52-week high of $12.75 on 02/28/24 and a 52-week low of $3.86 on 12/18/24. A 50-day SMA is recorded $4.94, while a 200-day SMA reached $6.87. Nevertheless, trading volume fell to 0.61 million shares from 0.52 million shares the previous day.
Support And Resistance Levels for Compass Pathways Plc ADR (CMPS)
According to the 24-hour chart, there is a support level at 3.95, which, if violated, would cause prices to drop to 3.77. In the upper region, resistance lies at 4.25. The next price resistance is at 4.37. RSI (Relative Strength Index) is 41.43 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.19, which suggests the price will decrease in the coming days. Percent R is at 73.33%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
